Day: October 26, 2024
Vera Therapeutics Announces 96-week eGFR Stabilization in ORIGIN Phase 2b Study of Atacicept in IgAN in a Late-Breaking Oral Presentation at the American Society of Nephrology Kidney Week 2024
Written by Customer Service on . Posted in Public Companies.
Celldex Announces Barzolvolimab Met All Primary and Secondary Endpoints with High Statistical Significance in Positive Phase 2 Study in Chronic Inducible Urticaria
Written by Customer Service on . Posted in Public Companies.
Pivotal VALIANT Results Presented at Kidney Week Highlight Strength of Pegcetacoplan Treatment Effect in Patients with C3G / Primary IC-MPGN
Written by Customer Service on . Posted in Public Companies.
Travere Therapeutics Presents Data Reinforcing Clinical Benefit of FILSPARI® (Sparsentan) in IgAN and Late-Breaking Presentation in FSGS at ASN Kidney Week 2024
Written by Customer Service on . Posted in Public Companies.
Vivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of Varoglutamstat on Kidney Function at ASN Kidney Week 2024
Written by Customer Service on . Posted in Public Companies.
Cielo Provides Virtual AGM Reminder and Announces Extension of Proxy Voting Deadline
Written by Customer Service on . Posted in Public Companies.
El Pollo Loco Turns Up The Heat with Exclusive Mango Habanero Flavor Test
Written by Customer Service on . Posted in Public Companies.